229 related articles for article (PubMed ID: 34617884)
1. NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load.
Pohlkamp T; Xian X; Wong CH; Durakoglugil MS; Werthmann GC; Saido TC; Evers BM; White CL; Connor J; Hammer RE; Herz J
Elife; 2021 Oct; 10():. PubMed ID: 34617884
[TBL] [Abstract][Full Text] [Related]
2. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.
Prasad H; Rao R
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6640-E6649. PubMed ID: 29946028
[TBL] [Abstract][Full Text] [Related]
3. Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer's disease.
Xian X; Pohlkamp T; Durakoglugil MS; Wong CH; Beck JK; Lane-Donovan C; Plattner F; Herz J
Elife; 2018 Oct; 7():. PubMed ID: 30375977
[TBL] [Abstract][Full Text] [Related]
4. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase-mediated regulation of endolysosomal pH.
Prasad H; Rao R
J Biol Chem; 2018 May; 293(18):6721-6735. PubMed ID: 29567836
[TBL] [Abstract][Full Text] [Related]
6. Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brain.
Lee Y; Miller MR; Fernandez MA; Berg EL; Prada AM; Ouyang Q; Schmidt M; Silverman JL; Young-Pearse TL; Morrow EM
Brain; 2022 Sep; 145(9):3187-3202. PubMed ID: 34928329
[TBL] [Abstract][Full Text] [Related]
7. Loss of Christianson Syndrome Na
Pescosolido MF; Ouyang Q; Liu JS; Morrow EM
J Neurosci; 2021 Nov; 41(44):9235-9256. PubMed ID: 34526390
[TBL] [Abstract][Full Text] [Related]
8. The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease.
Prasad H; Rao R
J Biol Chem; 2015 Feb; 290(9):5311-27. PubMed ID: 25561733
[TBL] [Abstract][Full Text] [Related]
9. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling.
Chen Y; Durakoglugil MS; Xian X; Herz J
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):12011-6. PubMed ID: 20547867
[TBL] [Abstract][Full Text] [Related]
10. Sodium-hydrogen exchanger 6 (NHE6) deficiency leads to hearing loss, via reduced endosomal signalling through the BDNF/Trk pathway.
Kucharava K; Brand Y; Albano G; Sekulic-Jablanovic M; Glutz A; Xian X; Herz J; Bodmer D; Fuster DG; Petkovic V
Sci Rep; 2020 Feb; 10(1):3609. PubMed ID: 32107410
[TBL] [Abstract][Full Text] [Related]
11. Endosomal Acid-Base Homeostasis in Neurodegenerative Diseases.
Prasad H; Rao R
Rev Physiol Biochem Pharmacol; 2023; 185():195-231. PubMed ID: 32737755
[TBL] [Abstract][Full Text] [Related]
12. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
Saul A; Wirths O
Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
[TBL] [Abstract][Full Text] [Related]
13. The Contributions of the Endolysosomal Compartment and Autophagy to APOEɛ4 Allele-Mediated Increase in Alzheimer's Disease Risk.
Asiamah EA; Feng B; Guo R; Yaxing X; Du X; Liu X; Zhang J; Cui H; Ma J
J Alzheimers Dis; 2024; 97(3):1007-1031. PubMed ID: 38306054
[TBL] [Abstract][Full Text] [Related]
14. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
16. Functional Assessment
Ouyang Q; Joesch-Cohen L; Mishra S; Riaz HA; Schmidt M; Morrow EM
eNeuro; 2019; 6(6):. PubMed ID: 31676550
[TBL] [Abstract][Full Text] [Related]
17. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
[TBL] [Abstract][Full Text] [Related]
18. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
19. A Christianson syndrome-linked deletion mutation (∆(287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death.
Ilie A; Gao AY; Reid J; Boucher A; McEwan C; Barrière H; Lukacs GL; McKinney RA; Orlowski J
Mol Neurodegener; 2016 Sep; 11(1):63. PubMed ID: 27590723
[TBL] [Abstract][Full Text] [Related]
20. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
